Market research and consulting
Custom research and consultancy to answer your business questions
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients, physicians and consumers to deliver integrated insights.
We have a wealth of experience with medical devices, in vitro and in vivo diagnostics, imaging equipment and e-health solutions. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
We also offer real-world insights with our range of cost-effective sydicated solutions:
Immunology, Virology, Oncology, Nephrology, Cardiovascular and others
Our online syndicated tracking programme provides global marketing teams with real-time access to the key dynamics driving their market. Using appropriately designed physician panels, we provide patient chart data for a broad range of therapeutic areas and geographies.
Immunology, Atopic Dermatitis, Chronic Pain, Diabetes, NASH and others
Our patient report series offer fresh insight into the behaviour, attitudes and needs of people living with different types of chronic illness, providing a map of the patient journey from pre-diagnosis to stabilisation.
- Some example case studiesHow we helped our client maximise uptake and fine-tune the marketing strategy for their vaccine product in China
The challenge:Our client’s vaccine to protect against a condition prevalent in older adults had recently launched and secondary research was required to enable them to understand more about their target healthcare consumer and attitudes to health, well-being and vaccination. They needed to build a complete picture of how consumers are influenced, such as whether they are more influenced by HCP advice or online forums and…read more »How we conducted conference research to understand physician reactions to abstracts presented in a virtual setting
Our client had planned to present new scientific data from its growing oncology portfolio and research pipeline at the Annual Meeting of The American Society of Clinical Oncology (ASCO).read more »How we supported forecasting for a new vaccine by identifying the optimal pricing strategy
The challengeOur client was looking to identify the price point that would maximise revenue from their new vaccine across 8 emerging markets in Latin America and Asia Pacific, as well as establish long-term projections for their forecasting model. In parallel, they needed to ensure widespread and rapid market penetration of the vaccine, taking into account factors such as consumer socio-economic group, age and household composition.…read more »
- Our latest white papersThe impact of COVID-19 on chronic disease management and the implications for pharma marketing
On February 11, 2020, COVID-19 was officially named by the World Health Organisation (WHO). Since then the novel coronavirus causing it, (a severe acute respiratory syndrome) has left its mark on almost every country in the world.read more »China: How to strategise and win in the world's fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region.read more »Are dual ARVs the new frontier in a maturing HIV market?
Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and the industry’s relationships with governments, patients and activists.read more »